COMPOSITIONS OF NUCLEIC ACID NANOSTRUCTURES FOR VACCINES AND METHODS OF USE THEREOF

EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION

NON-INVASIVE AGENT APPLICATOR

PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1

TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR GENE EDITING

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA

Epitope focusing by variable effective antigen surface concentration

PREPARATION METHOD AND APPLICATION OF INTERFERING PEPTIDE TARGETING SARS-CoV-2 N PROTEIN

MODIFIED IMMUNOGENIC PROTEINS

METHODS OF TREATING OR PREVENTING A VIRAL INFECTION USING BACTERIOPHAGES

CYTOPLASMIC TRANSDUCTION PEPTIDE AND INTRACELLULAR MESSENGER COMPRISING SAME

RETROVIRAL PARTICLE COMPRISING AT LEAST TWO ENCAPSIDATED NONVIRAL RNAS

Non-invasive agent applicator

Simian adenovirus vectors comprising the ChAd-157 fiber protein

Recombinant BCG expressing HIV-1 p24 using pMyong2 vector system and use thereof

Trimer stabilizing HIV envelope protein mutations

POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS

Epitope focusing by variable effective antigen surface concentration

RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION

FRATAXIN-SENSITIVE MARKERS FOR DETERMINING EFFECTIVENESS OF FRATAXIN REPLACEMENT THERAPY

Epitope focusing by variable effective antigen surface concentration

CYTOPLASMIC TRANSDUCTION PEPTIDE AND INTRACELLULAR MESSENGER COMPRISING SAME

Recombinant HIV epitopes and uses thereof

TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES

Trimer stabilizing HIV envelope protein mutations

Epitope focusing by variable effective antigen surface concentration

RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION

Retroviral particle comprising at least two encapsidated nonviral RNAs

Systems, methods and compositions for optical stimulation of target cells

DOUBLE ENGINEERED HIV-1 ENVELOPES

Non-Invasive Agent Applicator

HIV and immunogenic peptide sequences and compositions

Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides

DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE

Method for treating adenosine deaminase severe combined imunodeficiency

Modular antigen transportation molecules and uses thereof in animals

Recombinant isfahan viral vectors

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

Vaccine and therapeutic delivery system

Suicide contrast agents targeting HIV reservoirs for theranostic eradication

Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same

Method to kill pathogenic microbes in a patient

Method for optically controlling a neuron with a mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from natromonas pharaonis (NpHR)

Method of treating intracellular infection

Replication-competent adenoviral vectors

Replication-competent adenoviral vectors

HIV peptides and immunogenic compositions

Composition comprising a colloidal synthetic bioresorbable vector and a viral vector

Epitope focusing by variable effective antigen surface concentration

Treatment of cancers with immunostimulatory HIV tat derivative polypeptides

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR)

Neuron-specific retrograde transport vector

Peptide Sequences of HIV polypeptides and compositions thereof

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS

Optogenetic method for generating an inhibitory current in a mammalian neuron

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome

PEPTIDES SEQUENCES AND COMPOSITIONS

Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response

Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector

SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS

Pharmaceutical compositions containing 1-methyl-D-tryptophan

Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome

Replication-competent adenoviral vectors

GB virus C and methods of treating viral infections